Tower Research Capital LLC (Trc) Finch Therapeutics Group, Inc. Transaction History

Tower Research Capital LLC (Trc)

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 09, 2023	SELL	$0.34 - $0.56 $1,236 - $2,036	-3,637 Reduced 28.99%	8,908 $4,000
Q4 2022 Feb 10, 2023	BUY	$0.36 - $56.4 $4,516 - $707,538	12,545 New	12,545 $6,000
Q2 2022 Aug 15, 2022	SELL	$1.91 - $5.11 $5,731 - $15,335	-3,001 Reduced 89.9%	337 $1,000
Q1 2022 May 12, 2022	BUY	$5.02 - $10.47 $9,352 - $19,505	1,863 Added 126.31%	3,338 $17,000
Q4 2021 Feb 14, 2022	BUY	$8.95 - $16.88 $5,620 - $10,600	628 Added 74.14%	1,475 $15,000
Q3 2021 Nov 15, 2021	BUY	$12.2 - $16.75 $9,699 - $13,316	795 Added 1528.85%	847 $11,000
Q2 2021 Aug 16, 2021	BUY	$12.03 - $17.51 $625 - $910	52 New	52 $1,000

Ticker FNCH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 47,688,400
Market Cap $546M
Description
Finch Therapeutics Group, Inc., a clinical-stage microbiome therapeutics company, develops a novel class of orally administered biological drugs in the United States. The company's lead candidate is CP101, an orally administered microbiome capsule that is in Phase 3 clinical trial for the treatment of patients with recurrent Clostridioides diffi...

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.